Continuing Medical Education: Pharmacy CME: Cruise CME: Update on Indications, Interactions and Complications in the Use of Pharmaceuticals: Continuing Education Inc: Western Caribbean Cruise: December 26 - January 2, 2011
Continuing Education, Inc.
Update on Indications, Interactions and Complications in the Use of Pharmaceuticals
CME Sponsor:
Continuing Education Inc.
Ship/Location:
Holland America's ms Eurodam
Western Caribbean Cruise from Ft. Lauderdale, FL
Course Directors/Instructors:
George E. Mackinnon, PhD., RPh.
Chair and Professor
Department of Pharmacy Practice
Midwestern University College of Pharmacy
Glendale, Arizona
Karen Mackinnon, RPh
Assistant Professor
Department of Pharmaceutical Sciences at Midwestern University College of Pharmacy
Glendale, Arizona
Director of Professional Laboratories
Midwestern University College of Pharmacy
Registration Fee:
Physicians and Doctors of Pharmacy- $695
All Others- $450
Number of Credits:
14 AMA PRA Category 1 Credit(s)™
14 Contact Hours
14 Pharmacy CE Credits
More Info
Detailed Description:
Continuing Education Inc. is committed to developing and presenting the finest accredited continuing education programs for professionals that can be found.These programs are designed for the specific purpose of allowing the busy professional to obtain the educational course credits required to maintain licensure, while at the same time enjoying a family holiday without spending too much time away from his or her practice.
Intended Audience:
Pharmacists, Physicians, Physician Assistants, Nurses, and Nurse Practitioners
Learning Objectives:
After attending the following session individuals should be able to:
- Outline strategies for assessing and counseling patients on the use of OTC products.
- Describe patients attitude about monitoring and diagnostics for self-care.
- Explain issues related to drug safety, patient information, and other recent FDA activities such as prescription drug labeling, MedWatch, and post-marketing safety surveillance.
- Describe the mechanism of action and indications for newly approved drugs.
- Identify challenges and safety concerns regarding the medication approval and post-market surveillance processes.
- Describe the necessary points within the medication use system in which technology can be employed to reduce medical errors within health care.
- Describe the benefits and limitations of collaborative practice models in various patient care settings



